PLoS ONE (Jan 2023)

Infections and risk factors for infection-related mortality after pediatric allogeneic hematopoietic stem cell transplantation in Mexico: A single center retrospective study.

  • Elva Jiménez-Hernández,
  • Juan Carlos Núñez-Enriquez,
  • José Arellano-Galindo,
  • María de Los Angeles Del Campo-Martínez,
  • Perla Verónica Reynoso-Arenas,
  • Alfonso Reyes-López,
  • Alejandra Viridiana Delgado-Gaytan,
  • María Del Socorro Méndez-Tovar,
  • Teresa Marín-Palomares,
  • María Teresa Dueñas-Gonzalez,
  • Antonio Ortíz-Fernández,
  • Inés Montero-Ponce,
  • Laura Eugenia Espinosa-Hernández,
  • Nora Nancy Núñez-Villegas,
  • Ruy Pérez-Casillas,
  • Berenice Sánchez-Jara,
  • Angel García-Soto,
  • Annecy Nelly Herver-Olivares,
  • Ethel Zulie Jaimes-Reyes,
  • Hector Manuel Tiznado-García,
  • Octavio Martínez-Villegas,
  • Betzayda Valdez-Garibay,
  • Paloma Del Rocío Loza-Santiaguillo,
  • Xochiketzalli García-Jiménez,
  • Guadalupe Ortíz-Torres,
  • Gabriela Jazmin Fernández-Castillo,
  • Dulce María Aguilar-Olivares,
  • Luis Alejandro Díaz-Padilla,
  • Mario Alberto Noya-Rodríguez,
  • Mariana García-Jiménez,
  • Juan Manuel Mejía-Aranguré

DOI
https://doi.org/10.1371/journal.pone.0284628
Journal volume & issue
Vol. 18, no. 9
p. e0284628

Abstract

Read online

ObjectiveTo identify the type of infections and risk factors for infection-related mortality (IRM) after allogeneic hematopoietic stem cell transplantation (HSCT).MethodsRetrospective cohort study of patients ResultsData for 99 pediatric patients were analyzed. The myeloablative conditioning was the most used regimen (78.8%) and the hematopoietic stem cell source was predominantly peripheral blood (80.8%). Primary graft failure occurred in 19.2% of patients. Frequency of acute graft-versus-host disease was 46.5%. Total of 136 infectious events was recorded, the most common of which were bacterial (76.4%) followed by viral infection (15.5%) and then fungal infection (8.1%). The best predictors for infection subtypes where the following: a) for bacterial infection (the age groups of 10.1-15 years: aHR = 3.33; 95% CI: 1.62-6.85 and. >15 years: aHR = 3.34; 95% CI: 1.18-9.45); b) for viral infection (graft versus host disease: aHR = 5.36; 95% CI: 1.62-17.68), however, for fungal infection statistically significant predictors were not identified. Related mortality was 30% (n = 12). Increased risk for infection-related mortality was observed in patients with unrelated donor and umbilical cord stem cells recipients (HR = 3.12; 95% CI: 1.00-9.85).ConclusionsFrequencies of infections and infection-related mortality appear to be similar to those reported. Unrelated donors and stem cells from umbilical cord recipients were associated with a high risk of mortality.